1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow MRG 003: new trials by email Literature Review of MRG 003 trials Research Report on MRG 003
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study MRG 003, Pucotenlimab - Salivary Gland Carcinomas | Phase 2 | Recruiting | Ji Dongmei | 90 | 2026-03-19 | 2026-04-01 |
Ji Dongmei (1)
China (1)